Evidence map›Paper›PMID 40798971›Full record

ReviewCurrent stem cell research & therapy2026

Umbilical Cord Mesenchymal Stem Cells as a Meritorious Option to Treat Psoriasis.

Reza Arefnezhad, Saleheh Jahani, Aram Alipour, Dorrin Alipour Amini, Mohammad Mahdi Safarpour, Sharareh Jahangiri, Arian Karimi Rouzbahani, Hooman Zarei, Fatemeh Rezaei-Tazangi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current stem cell research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Reza ArefnezhadDepartment of Anatomy, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Saleheh JahaniDepartment of Pathology, University of California, San Diego, USA.
Aram AlipourDepartment of Biological Sciences, Faculty of Sciences and Converging Technologies, Islamic Azad University, Science and Research branch, Tehran, Iran.
Dorrin Alipour AminiDepartment of Biology, Faculty of Science, Oloum Tahghighat Branch, Islamic Azad University, Tehran, Iran.
Mohammad Mahdi SafarpourStudent Research Committee, School of Dentistry, Lorestan University of Medical Sciences, Khorramabad, Iran.
Sharareh JahangiriDepartment of Anesthesiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Arian Karimi RouzbahaniDepartment of Biology, Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.
Hooman ZareiDepartment of Anatomical Sciences, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Fatemeh Rezaei-TazangiDepartment of Anatomy, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is a chronic immune-mediated disease that affects a significant percentage of the global population. The pathogenesis of psoriasis involves the rapid turnover of skin cells and immune system dysregulation, particularly the T cell-mediated autoimmune response. Conventional treatments for Psoriasis include topical therapy, light therapy (phototherapy), and systemic medications; however, some limitations and diverse side effects have been mentioned for their usage. Therefore, increasing attention is being directed toward finding alternative therapeutic methods for psoriasis. Recently, Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) have gained attention for their potential in treating various diseases, including autoimmune disorders, cardiovascular conditions, and metabolic disorders. Multiple advantages have been reported for UC-MSCs, including noninvasive collection, low immunogenicity, and minimal ethical issues. The aim of this review was to explore the potential of UC-MSCs in the treatment of psoriasis.

Indexed as

Mesenchymal Stem CellsMesenchymal Stem Cell TransplantationPsoriasisUmbilical CordAnimalsHumansimmune cellsinflammationpathogenesisPsoriasisskin cellsumbilical cord mesenchymal stem cells

Identifiers

PMID40798971

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.